Project Details
| Status | Active |
|---|---|
| Effective start/end date | 01/6/20 → 11/9/26 |
Funding
- Genentech Incorporated: $45,422.09
Outcome Sciences: An Observational Study of Ocrelizumab-Treated Patients with Multiple Sclerosis to Determine the Incidence and Mortality Rates of Breast Cancer and All Malignancies (Verismo Study)
- Coyle, Patricia K (PI)
- McLinskey, Nancy (CoPI)
- Melville, Patricia (CoPI)
- Smith, Sandra (CoPI)
Project: Research